Showing 1 - 8 results of 8 for search 'Paolo Catarsi', query time: 0.03s Refine Results
  1. 1
    Digital PCR - Methods and Protocols

    Digital PCR - Methods and Protocols by Paolo Catarsi

    Published 2019-10-01
    Get full text
    Article
  2. 2
    Type 1 CALR mutation allele frequency correlates with CD34/CXCR4 expression in myelofibrosis-type megakaryocyte dysplasia: A mechanism of disease progression?

    Type 1 CALR mutation allele frequency correlates with CD34/CXCR4 expression in myelofibrosis-type megakaryocyte dysplasia: A mechanism of disease progression? by Giovanni Barosi, Rita Campanelli, Paolo Catarsi, Carlotta Abbà, Adriana Carolei, Margherita Massa, Robert Peter Gale, Vittorio Rosti

    Published 2024-01-01
    Get full text
    Article
  3. 3
    Clinical Relevance of <i>VEGFA</i> (rs3025039) +936 C>T Polymorphism in Primary Myelofibrosis: Susceptibility, Clinical Co-Variates, and Outcomes

    Clinical Relevance of <i>VEGFA</i> (rs3025039) +936 C>T Polymorphism in Primary Myelofibrosis: Susceptibility, Clinical Co-Variates, and Outcomes by Laura Villani, Adriana Carolei, Vittorio Rosti, Margherita Massa, Rita Campanelli, Paolo Catarsi, Carlotta Abbà, Robert Peter Gale, Giovanni Barosi

    Published 2021-08-01
    Get full text
    Article
  4. 4
    JAK2 V617F genotype is a strong determinant of blast transformation in primary myelofibrosis.

    JAK2 V617F genotype is a strong determinant of blast transformation in primary myelofibrosis. by Giovanni Barosi, Valentina Poletto, Margherita Massa, Rita Campanelli, Laura Villani, Elisa Bonetti, Gianluca Viarengo, Paolo Catarsi, Catherine Klersy, Vittorio Rosti

    Published 2013-01-01
    Get full text
    Article
  5. 5
    VEGFA rs3025039 is associated with phenotype severity of myelofibrosis‐type megakaryocyte dysplasia

    VEGFA rs3025039 is associated with phenotype severity of myelofibrosis‐type megakaryocyte dysplasia by Giovanni Barosi, Paolo Catarsi, Rita Campanelli, Margherita Massa, Adriana Carolei, Carlotta Abbà, Annalisa deSilvestri, Robert Peter Gale, Vittorio Rosti

    Published 2023-08-01
    Get full text
    Article
  6. 6
    VEGFA rs3025020 Polymorphism Contributes to CALR-Mutation Susceptibility and Is Associated with Low Risk of Deep Vein Thrombosis in Primary Myelofibrosis

    VEGFA rs3025020 Polymorphism Contributes to CALR-Mutation Susceptibility and Is Associated with Low Risk of Deep Vein Thrombosis in Primary Myelofibrosis by Laura Villani, Vittorio Rosti, Margherita Massa, Rita Campanelli, Paolo Catarsi, Adriana Carolei, Carlotta Abbà, Annalisa de Silvstri, Robert Peter Gale, Giovanni Barosi

    Published 2021-10-01
    Get full text
    Article
  7. 7
    Evidence that prefibrotic myelofibrosis is aligned along a clinical and biological continuum featuring primary myelofibrosis.

    Evidence that prefibrotic myelofibrosis is aligned along a clinical and biological continuum featuring primary myelofibrosis. by Giovanni Barosi, Vittorio Rosti, Elisa Bonetti, Rita Campanelli, Adriana Carolei, Paolo Catarsi, Antonina M Isgrò, Letizia Lupo, Margherita Massa, Valentina Poletto, Gianluca Viarengo, Laura Villani, Umberto Magrini

    Published 2012-01-01
    Get full text
    Article
  8. 8
    Circulating Mesenchymal Stromal Cells in Patients with Infantile Hemangioma: Evaluation of Their Functional Capacity and Gene Expression Profile

    Circulating Mesenchymal Stromal Cells in Patients with Infantile Hemangioma: Evaluation of Their Functional Capacity and Gene Expression Profile by Carlotta Abbà, Stefania Croce, Chiara Valsecchi, Elisa Lenta, Rita Campanelli, Alessia C. Codazzi, Valeria Brazzelli, Adriana Carolei, Paolo Catarsi, Gloria Acquafredda, Antonia Apicella, Laura Caliogna, Micaela Berni, Savina Mannarino, Maria A. Avanzini, Vittorio Rosti, Margherita Massa

    Published 2024-01-01
    Get full text
    Article

Search Tools: